EOM Pharmaceuticals Holdings, Inc. (OTCMKTS:IMUC – Get Free Report)’s stock price shot up 17.3% during trading on Thursday . The stock traded as high as $0.20 and last traded at $0.18. 297 shares traded hands during trading, a decline of 92% from the average session volume of 3,950 shares. The stock had previously closed at $0.15.
EOM Pharmaceuticals Stock Up 17.3 %
The firm’s 50 day moving average price is $0.23 and its 200-day moving average price is $0.27.
About EOM Pharmaceuticals
Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis.
Further Reading
- Five stocks we like better than EOM Pharmaceuticals
- How to Find Undervalued Stocks
- Comprehensive PepsiCo Stock Analysis
- Why Invest in 5G? How to Invest in 5G Stocks
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- Investing In Automotive Stocks
- 3 Steel Stocks Could Soar on New China Tariffs
Receive News & Ratings for EOM Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EOM Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
